Compare ABM & HTFL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | ABM | HTFL |
|---|---|---|
| Founded | 1909 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Diversified Commercial Services | |
| Sector | Finance | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.8B | 2.2B |
| IPO Year | 1994 | 2025 |
| Metric | ABM | HTFL |
|---|---|---|
| Price | $48.46 | $48.91 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 8 | 10 |
| Target Price | ★ $55.93 | $46.00 |
| AVG Volume (30 Days) | 468.7K | ★ 1.4M |
| Earning Date | 09-08-2026 | 11-11-2026 |
| Dividend Yield | ★ 2.41% | N/A |
| EPS Growth | ★ 102.34 | 82.37 |
| EPS | ★ 2.20 | N/A |
| Revenue | ★ $8,745,900,000.00 | $176,034,000.00 |
| Revenue This Year | $5.43 | $41.41 |
| Revenue Next Year | $3.48 | $24.15 |
| P/E Ratio | $22.10 | ★ N/A |
| Revenue Growth | 4.62 | ★ 39.92 |
| 52 Week Low | $36.96 | $20.13 |
| 52 Week High | $51.29 | $52.22 |
| Indicator | ABM | HTFL |
|---|---|---|
| Relative Strength Index (RSI) | 44.70 | 59.55 |
| Support Level | $46.06 | $46.44 |
| Resistance Level | $48.28 | $51.73 |
| Average True Range (ATR) | 1.03 | 2.06 |
| MACD | -0.24 | -0.45 |
| Stochastic Oscillator | 12.68 | 57.34 |
ABM Industries Inc is a provider of integrated facility solutions. It offers its solutions through five segments: Business and Industry, Manufacturing and Distribution, Education, Aviation and Technical solutions. The company derives the majority of its revenue from the business and industry segment, which encompasses janitorial, facilities engineering, and parking services for commercial real estate properties and sports and entertainment venues, hospitals, as well as vehicle maintenance and other services to rental car providers. The company mainly operates in the United States of America.
HeartFlow Inc is a commercial-stage medical technology company that provides software and artificial intelligence (AI) designed to deliver a non-invasive solution for diagnosing and managing coronary artery disease. The company operates and manages its business as a single reportable operating segment: non-invasive coronary artery disease detection solutions. Geographically, it operates in the United States and the rest of Europe, deriving the majority of its revenue from the United States. The company has developed three software products: Heartflow Roadmap Analysis, Heartflow FFRCT Analysis, and Heartflow Plaque Analysis.